1. Home
  2. BTBT vs RLMD Comparison

BTBT vs RLMD Comparison

Compare BTBT & RLMD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Bit Digital Inc.

BTBT

Bit Digital Inc.

SELL

Current Price

$1.22

Market Cap

427.6M

Sector

Finance

ML Signal

SELL

Logo Relmada Therapeutics Inc.

RLMD

Relmada Therapeutics Inc.

HOLD

Current Price

$3.42

Market Cap

461.9M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BTBT
RLMD
Founded
2015
2004
Country
United States
United States
Employees
N/A
N/A
Industry
Finance: Consumer Services
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
427.6M
461.9M
IPO Year
2017
2012

Fundamental Metrics

Financial Performance
Metric
BTBT
RLMD
Price
$1.22
$3.42
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
5
4
Target Price
$3.63
★ $10.75
AVG Volume (30 Days)
★ 19.5M
1.2M
Earning Date
11-13-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 45.28
EPS
N/A
★ N/A
Revenue
★ $113,560,320.00
$13,070.00
Revenue This Year
$33.25
N/A
Revenue Next Year
$107.68
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
5.10
★ 154.83
52 Week Low
$1.18
$1.80
52 Week High
$4.55
$8.00

Technical Indicators

Market Signals
Indicator
BTBT
RLMD
Relative Strength Index (RSI) 29.28 36.02
Support Level N/A $3.22
Resistance Level $1.75 $4.44
Average True Range (ATR) 0.09 0.19
MACD -0.06 0.00
Stochastic Oscillator 6.25 43.04

Price Performance

Historical Comparison
BTBT
RLMD

About BTBT Bit Digital Inc.

Bit Digital Inc is engaged in the Bitcoin mining business, Ethereum staking activities and specialized cloud-infrastructure services for artificial intelligence applications through its wholly owned subsidiaries. Its mining platform operates with the primary intent of accumulating bitcoin which may sell for fiat currency from time to time depending on market conditions. The Company has four reportable segments: digital asset mining, cloud services, colocation services, and ETH Staking. It generates majority of its revenue from digital asset mining.

About RLMD Relmada Therapeutics Inc.

Relmada Therapeutics Inc is a clinical-stage, publicly traded biotechnology company focused on the development of NDV-01 and sepranolone. NDV-01 is a novel, controlled-release intravesical formulation of gemcitabine and docetaxel. NDV-01 is currently in a Phase 2 clinical trial in Isreal to assess its safety and efficacy in patients with aggressive forms of non-muscle invasive bladder cancer (NMIBC). Sepranolone is a novel neurosteroid epimer of allopregnanolone. sepranolone is being developed for the potential treatment of Prader-Willi Syndrome, Tourette Syndrome, excessive tremor and other diseases related to excessive GABAergic activity.

Share on Social Networks: